Probing the links between in vitro potency, ADMET and physicochemical parameters

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nature reviews. Drug discovery

• Publication date

  2011-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/nrd3367PMID 21358739PMCID PMC6317702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs.

  2010cited by this paper
• Reaching Out to Collaborators: Crowdsourcing for Pharmaceutical Research

  2010cited by this paper
• Assessment of the blood-brain barrier in CNS drug discovery.

  2010cited by this paper
• How to improve R&D productivity: the pharmaceutical industry's grand challenge

  2010cited by this paper
• Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research

  2010cited by this paper
• Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability.

  2009cited by this paper
• The influence of lead discovery strategies on the properties of drug candidates

  2009cited by this paper
• Receptor Occupancy and Brain Free Fraction

  2009cited by this paper
• Using the Golden Triangle to optimize clearance and oral absorption.

  2009cited by this paper
• Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds.

  2009cited by this paper
• Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds

  2009cited by this paper
• Structure and organization of drug-target networks: insights from genomic approaches for drug discovery.

  2009cited by this paper
• Network pharmacology: the next paradigm in drug discovery.

  2008cited by this paper
• Generation of a set of simple, interpretable ADMET rules of thumb.

  2008cited by this paper
• Are the Chemical Structures in Your QSAR Correct

  2008cited by this paper
• Fragments, network biology and designing multiple ligands.

  2007cited by this paper
• Drug–target residence time and its implications for lead optimization

  2007cited by this paper
• Drug—target network

  2007cited by this paper
• The influence of drug-like concepts on decision-making in medicinal chemistry

  2007cited by this paper
• Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data

  2007cited by this paper
• Multi-target therapeutics: when the whole is greater than the sum of the parts.

  2007cited by this paper
• The human disease network

  2007cited by this paper
• Driving earlier clinical attrition: if you want to find the needle, burn down the haystack. Considerations for biomarker development.

  2007cited by this paper
• Network pharmacology

  2007cited by this paper
• Lead-like, drug-like or “Pub-like”: how different are they?

  2007cited by this paper
• Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs.

  2007cited by this paper
• How many drug targets are there?

  2006cited by this paper
• Drug–target residence time and its implications for lead optimization

  2006cited by this paper
• Dependence of molecular properties on proteomic family for marketed oral drugs.

  2006cited by this paper
• Fragment-based drug design: how big is too big?

  2006cited by this paper
• Lessons from the drug discovery of lapatinib, a dual ErbB1/2 tyrosine kinase inhibitor.

  2006cited by this paper
• Improving the in Vitro Prediction of in Vivo Central Nervous System Penetration: Integrating Permeability, P-glycoprotein Efflux, and Free Fractions in Blood and Brain

  2006cited by this paper
• Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits.

  2006cited by this paper
• Can we rationally design promiscuous drugs?

  2006cited by this paper
• Biological assay challenges from compound solubility: strategies for bioassay optimization.

  2006cited by this paper
• The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds.

  2006cited by this paper
• Avoiding physicochemical artefacts in early ADME-Tox experiments.

  2006cited by this paper
• Components of successful lead generation.

  2005cited by this paper
• A comprehensive listing of bioactivation pathways of organic functional groups.

  2005cited by this paper
• Application of pharmaceutical profiling assays for optimization of drug-like properties.

  2005cited by this paper
• Ligand efficiency indices as guideposts for drug discovery.

  2005cited by this paper
• The evolution of synthetic oral drug properties.

  2005cited by this paper
• Predicting protein druggability.

  2005cited by this paper
• Can the pharmaceutical industry reduce attrition rates?

  2004cited by this paper
• Drug-like properties: guiding principles for design - or chemical prejudice?

  2004cited by this paper
• Pursuing the leadlikeness concept in pharmaceutical research.

  2004cited by this paper
• Molecular properties that influence oral drug-like behavior.

  2004cited by this paper
• Time-related differences in the physical property profiles of oral drugs.

  2004cited by this paper
• Ligand efficiency: a useful metric for lead selection.

  2004cited by this paper
• A 'rule of three' for fragment-based lead discovery?

  2003cited by this paper
• The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues.

  2003cited by this paper
• A comparison of physiochemical property profiles of development and marketed oral drugs.

  2003cited by this paper
• Is There a Difference between Leads and Drugs? A Historical Perspective

  2001cited by this paper
• Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• The maximal affinity of ligands.

  1999cited by this paper
• The Design of Leadlike Combinatorial Libraries.

  1999cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

  1997cited by this paper
• Drug prototypes and their exploitation

  1996cited by this paper
• How to secure a corporate partner in Japan

  1993cited by this paper
• Simple Method of Calculating Octanol/Water Partition Coefficient.

  1992cited by this paper
• Functional group contributions to drug-receptor interactions.

  1984cited by this paper

• In silico Approaches for Effective and Potential Biocontrol Agents against Targeting Chitin Synthase Protein of Pathogenic Fungus Alternaria alternata (Fr.) Keissl. of Onion

  2026cites this paper
• An exhaustive computational bioassessment of plant‐derived terpenoids as potential SARS‐CoV‐2 inhibitors

  2026cites this paper
• Synthesis, docking, SAR and ADMET evaluation of novel pyrrolo[3,4-c]pyrazole-4,6-dione derivatives

  2026influential citation
• Multi-objective QSAR prediction of ERα antagonists via SHAP-based interpretation

  2026cites this paper
• Graph-based transformer to predict the octanol-water partition coefficient.

  2026cites this paper
• What Happens in Successful Optimizations? A Survey of 2018-2024 Literature.

  2026cites this paper
• Structural and computational investigation of the novel Isatin derivative: Exploration of the pharmacokinetic and drug properties

  2026cites this paper
• ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment

  2025cites this paper
• ADME related patterns to predict the prognosis and immune therapy of colon cancer patients

  2025cites this paper
• FROGENT: An End-to-End Full-process Drug Design Multi-Agent System

  2025cites this paper
• Design, synthesis, molecular modeling, and antiproliferative evaluation of new 2-oxoindolin-3-ylidene thiazole derivatives.

  2025cites this paper
• Biological evaluation and molecular docking studies of novel aza-acyclic nucleosides as putative antimicrobial, anticancer, and antioxidant agents

  2025cites this paper
• Combination of Ethylene glycol and TBAB-mediated pyrimidine fused heterocyclic derivatives: Synthesis, in silico, and in vitro anti-diabetic and anti-microbial studies

  2025cites this paper
• Tertiary Alcohol: Reaping the Benefits but Minimizing the Drawbacks of Hydroxy Groups in Drug Discovery.

  2025cites this paper
• MTGIB-UNet: A Multi-Task Graph Information Bottleneck and Uncertainty Weighted Network for ADMET Prediction

  2025cites this paper
• Inhibitory Potential of the Drimane Sesquiterpenoids Isotadeonal and Polygodial in the NF-kB Pathway

  2025cites this paper
• Advancing N,N'-disubstituted diamines in antimalarial drug development: Structure-activity relationships and mechanistic studies.

  2025cites this paper
• Discovery of novel harmine derivatives as potent, selective, and brain permeable GSK3β inhibitors with effective In vivo anti-AD activity.

  2025cites this paper
• Potencial antiangiogênico do derivado 9-aminoacridínico ACS-AZ-10:

  2025cites this paper
• Structural analysis and computational studies of cyclopropane derivative as an anti- Alzheimer’s agent: Investigation of interactions by X-ray crystallography, DFT, molecular docking, and ADMET approaches

  2025cites this paper
• Unifying principles for the design and evaluation of natural product-inspired compound collections

  2025cites this paper
• New indolin-2-ones, possessing sunitinib scaffold as HDAC inhibitors and anti-cancer agents with potential VEGFR inhibition activity; design, synthesis and biological evaluation.

  2025cites this paper
• In Vitro ADME Profiling of PROTACs: Successes, Challenges, and Lessons Learned from Analysis of Clinical PROTACs from a Diverse Physicochemical Space.

  2025cites this paper
• New Molecular Hybrids of Spirochromanone and Carbamide: Design, Synthesis, Docking and in vitro Anticancer Studies

  2025cites this paper
• Cytotoxic Profiling of Korea Chemical Bank Diversity Library.

  2025cites this paper
• Toxicity Assessment of Allium sativa and Zingiber officinale using in vivo and in silico Approaches in Mice

  2025cites this paper
• Synthesis, structure, DNA docking, pharmacokinetics/ADMET, Hirshfeld surface analysis, and antimicrobial studies on biphenyl appended pyrrolidine complexes

  2025cites this paper
• EvaMol: A python tool for evaluating molecules in hit-to-lead optimization

  2025cites this paper
• Modular Access to Sulfondiimidoyl Fluorides by NaH-Mediated Fluorination of Sulfenamides.

  2025cites this paper
• Pharmacomodulation of the Redox-Active Lead Plasmodione: Synthesis of Substituted 2-Benzylnaphthoquinone Derivatives, Antiplasmodial Activities, and Physicochemical Properties

  2025cites this paper
• Tetrahydroisoquinoline derivative: Design, synthesis, characterization, crystal structure investigation, and computational studies approach

  2025cites this paper
• Drug screens using the nematode Caenorhabditis elegans

  2025cites this paper
• Role of ADME genes in breast cancer prognosis: an analysis of risk scoring models based on multi-omics data

  2025cites this paper
• Labdane Diterpenoids from Leonotis ocymifolia with Selective Cytotoxic Activity Against HCC70 Breast Cancer Cell Line

  2025cites this paper
• Enhancing Chemical Explainability Through Counterfactual Masking

  2025cites this paper
• Therapeutic Evaluation of Gut Microbiota-Derived Metabolites (GMDM) through Computational Approaches: A Narrative Review

  2025cites this paper
• Synthesis and structural studies of novel N-(2,6-dichlorophenyl)-4-[4-(methylsulfonyl) phenyl]-1,3-thiazol-2-amine: insights from crystallographic to computational studies

  2025cites this paper
• Facile one-pot synthesis and in silico study of new heterocyclic scaffolds with 4-pyridyl moiety: Mechanistic insights and X-ray crystallographic elucidation

  2024cites this paper
• Identification and functional prediction of new triterpenoids from Alismatis Rhizoma using HPLC-HRMS and in-silico analysis

  2024cites this paper
• Tackling assay interference associated with small molecules

  2024cites this paper
• Reinvent Aliphatic Arsenicals as Reversible Covalent Warheads toward Targeted Kinase Inhibition and Non-acute Promyelocytic Leukemia Cancer Treatment.

  2024cites this paper
• Toward Dose Prediction at Point of Design.

  2024cites this paper
• Eliminating malaria transmission requires targeting immature and mature gametocytes through lipoidal uptake of antimalarials

  2024cites this paper
• Unveiling the Potential of Ent-Kaurane Diterpenoids: Multifaceted Natural Products for Drug Discovery

  2024cites this paper
• Anxiolytic Efficacy of Indirubin: In Vivo Approach Along with Receptor Binding Profiling and Molecular Interaction with GABAergic Pathways

  2024cites this paper
• Insight into antioxidant-like activity and computational exploration of identified bioactive compounds in Talinum triangulare (Jacq.) aqueous extract as potential cholinesterase inhibitors

  2024cites this paper
• Synthesis, molecular docking study, and biological evaluation and of new thiadiazole and thiazole derivatives incorporating isoindoline-1,3-dione moiety as anticancer and antimicrobial agents

  2024cites this paper
• Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control

  2024cites this paper
• Design, Synthesis, Anti‐Cancer, Anti‐Inflammatory and In Silico Studies of 3‐Substituted‐2‐Oxindole Derivatives

  2024cites this paper
• Closing the Design-Make-Test-Analyze Loop: Interplay between Experiments and Predictions Drives PROTACs Bioavailability.

  2024cites this paper
• HormoNet: a deep learning approach for hormone-drug interaction prediction

  2024cites this paper
• Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates.

  2024cites this paper
• Which cryptic sites are feasible drug targets?

  2024cites this paper
• Green Biocatalyst for Ultrasound-Assisted Thiazole Derivatives: Synthesis, Antibacterial Evaluation, and Docking Analysis

  2024cites this paper
• Designed dualsteric modulators: A novel route for drug discovery.

  2024cites this paper
• In vitro pharmacologic profiling aids systemic toxicity assessment of chemicals.

  2024cites this paper
• Evaluation and identification of green pharmacophore as a potent inhibitor of human tyrosinase related protein 1 using molecular drug interaction, drug likeness and ADMET analyses

  2024cites this paper
• Characterisation of RNA guanine-7 methyltransferase (RNMT) using a small molecule approach

  2024cites this paper
• Analysis of SIKVAV’s receptor affinity, pharmacokinetics, and pharmacological characteristics: a matrikine with potent biological function

  2024cites this paper
• Formulation and Ex Vivo Evaluation of Ivermectin Within Different Nano-Drug Delivery Vehicles for Transdermal Drug Delivery

  2024cites this paper
• Green synthesis of hydrazono-thiazolones using vitamin B1 and their antibacterial implications

  2024cites this paper
• Formulation, characterization and evaluation of anti-breast cancer activity of 2-carene nanoemulsion; in silico, in vitro and in vivo study

  2024cites this paper
• Evaluation of anticancer activity of novel platinum(II) bis(thiosemicarbazone) complex against breast cancer.

  2024cites this paper
• DrugGym: A testbed for the economics of autonomous drug discovery

  2024cites this paper
• Network Pharmacology-Based Virtual Screening of Chemical Constituents from Vitexnegundo Linn's Discovered Novel Molecular Targets for Breast Cancer Treatment.

  2024cites this paper
• Dual active pyrimidine-based carbocyclic nucleoside derivatives: synthesis, and in silico and in vitro anti-diabetic and anti-microbial studies

  2024cites this paper
• Mycosporine-Like Amino Acids as a Potential Inhibitor of Tyrosinase-Related Protein 1: Computational Screening, Pharmacokinetics, and Molecular Dynamics Simulation

  2024cites this paper
• Impact of 2-hydroxypropyl-β-cyclodextrin inclusion complex formation on dopamine receptor-ligand interaction - A case study.

  2024cites this paper
• Time-Dependent Comparison of the Structural Variations of Natural Products and Synthetic Compounds

  2024cites this paper
• Analysis of the Physicochemical Properties of Anti-Schistosomal Compounds to Identify Next-Generation Leads

  2024cites this paper
• Recent advances on molecular dynamics-based techniques to address drug membrane permeability with atomistic detail

  2023cites this paper
• Computational screening of natural MtbDXR inhibitors for novel anti-tuberculosis compound discovery

  2023cites this paper
• Rational Design of Multifunctional Ferulic Acid Derivatives Aimed for Alzheimer’s and Parkinson’s Diseases

  2023cites this paper
• Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor

  2023cites this paper
• In Silico Identification and Analysis of Potentially Bioactive Antiviral Phytochemicals against SARS-CoV-2: A Molecular Docking and Dynamics Simulation Approach

  2023cites this paper
• Translatability of in vitro potency to clinical efficacious exposure: A retrospective analysis of FDA‐approved targeted small molecule oncology drugs

  2023cites this paper
• Antiproliferative Activities and SwissADME Predictions of Physicochemical Properties of Carbonyl Group‐Modified Rotenone Analogues

  2023cites this paper
• Towards holistic Compound Quality Scores (CQS): Extending ligand efficiency indices with compound pharmacokinetic (PK) characteristics.

  2023cites this paper
• Potential antiviral activities of chrysin against hepatitis B virus

  2023cites this paper
• Using Machine Learning To Predict Partition Coefficient (Log P) and Distribution Coefficient (Log D) with Molecular Descriptors and Liquid Chromatography Retention Time

  2023cites this paper
• Privileged heterocycles for DNA-encoded library design and hit-to-lead optimization.

  2023cites this paper
• Bioinformatic analysis of single-cell RNA sequencing dataset dissects cellular heterogeneity of triple-negative breast cancer in transcriptional profile, splicing event and crosstalk network

  2023cites this paper
• An overview of compound properties, multiparameter optimization, and computational drug design methods for PARP-1 inhibitor drugs.

  2023cites this paper
• Indolyl‐4H‐Chromene Derivatives as Antibacterial Agents: Synthesis, in Vitro and in Silico Studies

  2023cites this paper
• Development of Novel Pyrrole Derivatives and Their Cinnamic Hybrids as Dual COX-2/LOX Inhibitors

  2023cites this paper
• Ligand’s Partition to the Lipid Bilayer Should Be Accounted for When Estimating Their Affinity to Proteins

  2023cites this paper
• Exploring the known chemical space of the plant kingdom: insights into taxonomic patterns, knowledge gaps, and bioactive regions

  2023cites this paper
• Ferrocene-triazole conjugates: do we know why they are biologically active?

  2023cites this paper
• Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems

  2023cites this paper
• Exploring the Potential of Compounds Isolated from Laranthus micranthus for the Treatment of Benign Prostatic Hyperplasia: Comprehensive Studies on Spectroscopic, Reactivity, and Biological Activity

  2023cites this paper
• Advances in Computational Approaches for Estimating Passive Permeability in Drug Discovery

  2023cites this paper
• Drug Discovery Based on Fluorine-Containing Glycomimetics

  2023cites this paper
• CMAUP database update 2024: extended functional and association information of useful plants for biomedical research

  2023cites this paper
• G Protein-Coupled Receptors: Immobilization and Applications in Drug Discovery

  2023cites this paper
• Selecting the appropriate indirect viability assay for 3D paper-based cultures: a data-driven study.

  2023cites this paper
• Synthesis, characterization and anti-breast cancer potential of an incensole acetate nanoemulsion from Catharanthus roseus essential oil; in silico, in vitro, and in vivo study

  2023cites this paper
• Extending ligand efficacy indices with compound pharmacokinetic characteristics towards holistic Compound Quality Scores

  2023cites this paper
• Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors

  2022cites this paper
• Adaptive boost approach for possible leads of triple-negative breast cancer

  2022cites this paper
• Efficient Oxidative Dearomatisations of Substituted Phenols Using Hypervalent Iodine (III) Reagents and Antiprotozoal Evaluation of the Resulting Cyclohexadienones against T. b. rhodesiense and P. falciparum Strain NF54

  2022cites this paper